Clinical information
Vaccines help prevent infections, transmission and thus the spread of diseases or pathogens such as tetanus, diphtheria, Bordetella pertussis, tick-borne encephalitis virus (TBE), measles virus, mumps virus, rubella virus or varicella zoster virus (VZV).
Diagnostics
The assessment of the immune status by means of IgG antibody detection is only possible for some pathogens. It requires, among others, standardised antibody detection based on international reference preparations and the availability of a cut-off to distinguish between existing and non-existing immunity. Such cut-offs have been described for tetanus, diphtheria, measles, rubella, VZV and TBE. For mumps and pertussis, however, there are currently no known immunity cut-offs or markers that are correlates of immune protection.
Methods
| Technology | Parameter | Substrate | Species | Calibration | Ig Class | Format | Order No. |
|---|---|---|---|---|---|---|---|
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | 5/25/50/100/175/230 U/ml | IgG |
96 x 01 |
EI 2661-9601-2L G |
| ELISA |
Anti-TBE Virus CSF ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgM |
96 x 01 |
EI 2661-9601-2L M | |
| ELISA |
CSQ pair of controls anti-VZV (IgG) |
IgG |
02 x 20 |
CK 2650-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Rubella virus (IgG) |
IgG |
02 x 20 |
CK 2590-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Measles virus (IgG) |
IgG |
02 x 20 |
CK 2610-0220-L G | |||
| ELISA |
CSQ pair of controls anti-Mumps virus (IgG) |
IgG |
02 x 20 |
CK 2630-0220-L G | |||
| ELISA |
CSF: Anti-Rubella Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens, strain "HPV-77" |
5/25/50/100/175/230 U | IgG |
96 x 01 |
EI 2590-9601-L G |
| ELISA |
CSF: Anti-Measles Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens from Measles virus |
5/25/50/100/175/230 U | IgG |
96 x 01 |
EI 2610-9601-L G |
| ELISA |
CSF: Anti-Mumps Virus ELISA (IgG) Sample type: CSF/serum pair |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
5/25/50/100 U | IgG |
96 x 01 |
EI 2630-9601-L G |
| IIFT | TBE virus (TBEV) |
infected and non- infected cells (2 BIOCHIPs per field) |
EU 14 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005 G FI 2661-1005 M FI 2661-1010 G FI 2661-1010 M |
|
| IIFT |
Flavivirus Mosaic 1 TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) |
4 BIOCHIPs per field: infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2661-1005-1 G FI 2661-1005-1 M FI 2661-1010-1 G FI 2661-1010-1 M |
|
| IIFT |
Flavivirus Profile 2 upper row: TBE virus (TBEV) West Nile virus (WNV) Japanese encephalitis virus (JEV) Yellow fever virus (YFV) bottom row: Dengue virus types 1 - 4 (DENV) |
infected cells infected cells infected cells infected cells infected cells |
EU 14 EU 14 EU 14 EU 14 EU 14 |
IgG IgM IgG IgM |
10 x 05 10 x 05 20 x 05 20 x 05 |
FI 2661-1005-2 G FI 2661-1005-2 M FI 2661-2005-2 G FI 2661-2005-2 M |
|
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgG) tick-borne encephalitis virus |
antigen-coated microplate wells |
TBE viral proteins | IgG |
96 x 01 |
EI 2661-9601-2 G | |
| ELISA |
Anti-TBE Virus ELISA 2.0 (IgM) tick-borne encephalitis virus |
antigen-coated microplate wells |
semi-quantitative | IgM |
96 x 01 |
EI 2661-9601-2 M | |
| IIFT |
Varicella zoster virus (VZV) |
infected cells | EU 168 | IgG IgM IgG IgM |
10 x 05 10 x 05 10 x 10 10 x 10 |
FI 2650-1005 G FI 2650-1005 M FI 2650-1010 G FI 2650-1010 M |
|
| ELISA |
Anti-VZV ELISA (IgA) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
semi-quantitative | IgA |
96 x 01 |
EI 2650-9601 A |
| ELISA |
Anti-VZV ELISA (IgG) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
10/100/500/5000 IU/l | IgG |
96 x 01 |
EI 2650-9601 G |
| ELISA |
Anti-VZV ELISA (IgM) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV |
semi-quantitative | IgM |
96 x 01 |
EI 2650-9601 M |
| ELISA |
Avidity: Anti-VZV ELISA (IgG) Varicella zoster virus avidity determination |
antigen-coated microplate wells |
native antigens from VZV |
10/100/500/5000 IU/l | IgG |
96 x 01 |
EI 2650-9601-1 G |
| ELISA |
Anti-VZV ELISA 2.0 (IgG) Varicella zoster virus |
antigen-coated microplate wells |
native antigens from VZV | IgG |
96 x 01 |
EI 2650-9601-2 G | |
| ELISA |
Anti-VZV Glycoprotein ELISA (IgM) Varicella zoster virus |
antigen-coated microplate wells |
native glycoproteins from VZV |
semi-quantitative | IgM |
96 x 01 |
EI 2650-9601-2 M |
| ChLIA | IDS VZV IgG | antigenic coated magnetic particles | VZV virus antigen |
quantitative |
50 x 01 |
IS-ID59031 | |
| ChLIA | IDS MMV IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID59301 | ||
| ChLIA | IDS VZV IgM | antigenic coated magnetic particles | VZV virus antigen |
quantitative |
50 x 01 |
IS-ID60031 | |
| ChLIA | IDS MMV IgM Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID60301 | ||
| EUROArray | EUROArray HPV |
MN 2540-0505 MN 2540-0803 MN 2540-1005 MN 2540-2005 |
|||||
| ELISA |
Avidity: Anti-Rubella Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
native antigens, strain "HPV-77" |
1/10/50/200 IU/ml | IgG |
96 x 01 |
EI 2590-9601-1 G |
| ELISA | Anti-Rubella Virus Glycoprotein ELISA (IgM) |
antigen-coated microplate wells |
native glycoproteins, strain "HPV-77" |
semi-quantitative | IgM |
96 x 01 |
EI 2590-9601-2 M |
| ELISA | Anti-Rubella Virus ELISA 2.0 (IgG) |
antigen-coated microplate wells |
Recombinant Rubella virus antigens |
IgG |
96 x 01 |
EI 2590-9601-3 G | |
| ChLIA | IDS Rubella IgG | antigenic coated magnetic particles | Rubella antigen |
quantitative |
100 x 01 |
IS-ID52011 | |
| ChLIA | IDS Rubella IgM | Anti-IgM-coated magnetic particles | Conjugate: Rubella antigen |
quantitative |
100 x 01 |
IS-ID52021 | |
| ChLIA | IDS Rubella Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID52301 | ||
| ChLIA | IDS Rubella IgG Avidity | antigenic coated magnetic particles | Rubella antigen |
quantitative |
50 x 01 |
IS-ID53011 | |
| ChLIA | IDS Rubella Avidity Control Set | 3 x 1.0 ml Control 1/2 | human serum |
2 concentrations |
IS-ID53301 | ||
| ELISA | Anti-Bordetella pertussis toxin ELISA (IgA) |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
2/10/25/50 IU/ml | IgA |
96 x 01 |
EI 2050-9601 A |
| ELISA | Anti-Bordetella pertussis toxin ELISA (IgG) |
antigen-coated microplate wells |
natives Bordetella pertussis toxin |
5/25/100/200 IU/ml | IgG |
96 x 01 |
EI 2050-9601 G |
| ELISA | Anti-Bordetella pertussis ELISA (IgM) |
antigen-coated microplate wells |
inactivated Bordetella pertussis lysate |
semi-quantitative | IgM |
96 x 01 |
EI 2050-9601 M |
| ELISA | Anti-Bordetella FHA ELISA (IgA) |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
2/10/25/50 IU/ml | IgA |
96 x 01 |
EI 2050-9601-3 A |
| ELISA | Anti-Bordetella FHA ELISA (IgG) |
antigen-coated microplate wells |
native Bordetella pertussis filamentous haemagglutinin |
5/25/100/200 IU/ml | IgG |
96 x 01 |
EI 2050-9601-3 G |
| ELISA | Anti-Influenza A Virus ELISA (IgA) |
antigen-coated microplate wells |
strains "Texas" (H3N2), "California" (H1N1) and "Singapore" (H1N1) |
semi-quantitative | IgA |
96 x 01 |
EI 2691-9601 A |
| ELISA | Anti-Influenza A Virus ELISA (IgG) |
antigen-coated microplate wells |
strains "Texas" (H3N2), "California" (H1N1) and "Singapore" (H1N1) |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2691-9601 G |
| ELISA | Anti-Influenza B Virus ELISA (IgA) |
antigen-coated microplate wells |
strain"Hong Kong 5/72" | semi-quantitative | IgA |
96 x 01 |
EI 2692-9601 A |
| ELISA | Anti-Influenza B Virus ELISA (IgG) |
antigen-coated microplate wells |
strain"Hong Kong 5/72" | 2/20/200 RU/ml | IgG |
96 x 01 |
EI 2692-9601 G |
| EUROLINE |
positive control serum: IgA, human, 50x concentrated for Bordetella pertussis |
IgA |
05 x 07 |
CL 2050-0507 A | |||
| EUROLINE |
positive control serum: IgG, human, 50x concentrated for Bordetella pertussis |
IgG |
05 x 07 |
CL 2050-0507 G | |||
| EUROLINE |
EUROLINE Bordetella pertussis (IgA) (FHA, PT, ACT separately) |
EUROLINE | IgA IgA |
16 x 01 240 x 01 |
DN 2050-1601 A DN 2050-24001 A |
||
| EUROLINE |
EUROLINE Bordetella pertussis (IgG) (FHA, PT, ACT separately) |
EUROLINE | IgG IgG |
16 x 01 240 x 01 |
DN 2050-1601 G DN 2050-24001 G |
||
| ELISA | Anti-Diphtheria Toxoid ELISA (IgG) |
antigen-coated microplate wells |
inactivated diphtheria toxin |
0.01/0.1/1/2 IU/ml | IgG |
96 x 01 |
EI 2040-9601 G |
| ELISA | Anti-Tetanus Toxoid ELISA (IgG) |
antigen-coated microplate wells |
inactivated tetanus toxin |
0,01/0,1/1/2/5 IU/ml | IgG |
96 x 01 |
EI 2060-9601 G |
| ELISA | Anti-Measles Virus ELISA (IgG) |
antigen-coated microplate wells |
native antigens from Measles virus |
50/250/1000/5000 IU/l | IgG |
96 x 01 |
EI 2610-9601 G |
| ELISA | Anti-Measles Virus ELISA (IgM) |
antigen-coated microplate wells |
native antigens from Measles virus |
semi-quantitative | IgM |
96 x 01 |
EI 2610-9601 M |
| ELISA |
Avidity: Anti-Measles Virus ELISA (IgG) avidity determination |
antigen-coated microplate wells |
native antigens from Measles virus |
50/250/1000/5000/5000 IU/l | IgG |
96 x 01 |
EI 2610-9601-1 G |
| ELISA | Anti-Measles Virus ELISA 2.0 (IgG) |
antigen-coated microplate wells |
native antigens from Measles virus |
quantitative | IgG |
96 x 01 |
EI 2610-9601-2 G |
| ELISA | Anti-Measles Virus NP ELISA (IgM) |
antigen-coated microplate wells |
recombinant nucleoprotein from Measles virus |
semi-quantitative | IgM |
96 x 01 |
EI 2610-9601-4 M |
| ELISA | Anti-Mumps Virus ELISA (IgG) |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2630-9601 G |
| ELISA | Anti-Mumps Virus ELISA (IgM) |
antigen-coated microplate wells |
native antigens, strain "Enders" (ATCC VR-106) |
semi-quantitative | IgM |
96 x 01 |
EI 2630-9601 M |
| ELISA |
Anti-Mumps Virus AT ELISA (IgG) strains "Enders" and "Jeryl Lynn" |
antigen-coated microplate wells |
native antigens, strains "Enders" (ATCC VR-106) and "Jeryl Lynn" |
2/20/200 RU/ml | IgG |
96 x 01 |
EI 2630-9601-3 G |
| ELISA | Anti-Mumps Virus ELISA (G5) (IgM) |
antigen-coated microplate wells |
native antigens, genotype "G5" |
semi-quantitative | IgM |
96 x 01 |
EI 2630-9601-5 M |
| ChLIA | IDS Measles IgG | antigenic coated magnetic particles | Measles virus antigen |
quantitative |
50 x 01 |
IS-ID59011 | |
| ChLIA | IDS Mumps IgG | antigenic coated magnetic particles | Mumps virus antigen |
quantitative |
50 x 01 |
IS-ID59021 | |
| ChLIA | IDS Measles IgM | antigenic coated magnetic particles | Measles virus antigen |
quantitative |
50 x 01 |
IS-ID60011 | |
| ChLIA | IDS Mumps IgM | antigenic coated magnetic particles | Mumps virus antigen |
quantitative |
50 x 01 |
IS-ID60021 | |
| ChLIA | IDS Tetanus IgG | antigenic coated magnetic particles | Tetanus toxoid antigen |
quantitative |
100 x 01 |
IS-ID61011 | |
| ChLIA | IDS Tetanus IgG Control Set | 3 x 1.5 ml Control 1/2 | human serum |
2 concentrations |
IS-ID61301 | ||
|
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC. 1 Product manufactured by third party. Please contact your local Euroimmun representative for more information. | |||||||